abrdn Life Sciences Investors
HQL
56 hedge funds and large institutions have $61M invested in abrdn Life Sciences Investors in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 5 closing their positions.
64% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 14
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
2% more funds holding
Funds holding: 55 → 56 (+1)
1% more capital invested
Capital invested by funds: $60.1M → $61M (+$895K)
0.59% more ownership
Funds ownership: 14.44% → 15.02% (+0.59%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$1.11M |
| 2 |
Morgan Stanley
New York
|
+$550K |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$542K |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$436K |
| 5 |
FHA
Flagship Harbor Advisors
Boston,
Massachusetts
|
+$419K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
-$825K |
| 2 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$371K |
| 3 |
CAN
Claraphi Advisory Network
Aliso Viejo,
United States
|
-$300K |
| 4 |
MIC
Meridian Investment Counsel
Lafayette,
California
|
-$199K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$127K |
HQL Hedge Fund Activity: Q1 2018 in Review
56 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2018, worth a combined $61M — up 1.5% from $60.1M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new HQL positions and 5 closed out — a net gain of 1 holder — while 23 added to existing stakes and 14 trimmed.
The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $1.11M. The largest seller was LPL Financial, cutting an estimated $825K.
- 56 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2018, up from 55 in Q4 2017.
- Funds reported $61M of abrdn Life Sciences Investors stock for Q1 2018, up 1.5% quarter-over-quarter.
- 6 funds opened new abrdn Life Sciences Investors positions in Q1 2018 and 5 closed out, a net change of +1 holder.
- The largest abrdn Life Sciences Investors buyer in Q1 2018 was Wolverine Asset Management, an estimated $1.11M added.
- The largest abrdn Life Sciences Investors seller in Q1 2018 was LPL Financial, an estimated $825K sold.
Based on aggregated 13F filings for Q1 2018.